BioSyent Inc. (OTCMKTS:BIOYF) Sees Significant Growth in Short Interest

BioSyent Inc. (OTCMKTS:BIOYFGet Free Report) was the target of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 1,919 shares, a growth of 89.6% from the May 14th total of 1,012 shares. Based on an average daily volume of 9,933 shares, the days-to-cover ratio is currently 0.2 days.

BioSyent Stock Down 0.1%

OTCMKTS BIOYF opened at $10.00 on Friday. The firm’s fifty day simple moving average is $10.46 and its two-hundred day simple moving average is $10.08. BioSyent has a 12-month low of $7.63 and a 12-month high of $12.00.

BioSyent Company Profile

(Get Free Report)

BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.

BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.

See Also

Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.